Immuneering Corp (IMRX)
1.56
+0.03
(+1.96%)
USD |
NASDAQ |
May 02, 16:00
1.56
0.00 (0.00%)
After-Hours: 16:48
Immuneering Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.317M |
| September 30, 2022 | 0.5061M |
| June 30, 2022 | 0.9498M |
| March 31, 2022 | 1.516M |
| December 31, 2021 | 2.08M |
| Date | Value |
|---|---|
| September 30, 2021 | 2.556M |
| June 30, 2021 | 2.756M |
| March 31, 2021 | 2.577M |
| December 31, 2020 | 2.312M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.317M
Minimum
Dec 2022
2.756M
Maximum
Jun 2021
1.730M
Average
2.08M
Median
Dec 2021
Revenue (TTM) Benchmarks
| Geron Corp | 0.237M |
| SELLAS Life Sciences Group Inc | -- |
| Elicio Therapeutics Inc | -- |
| Vistagen Therapeutics Inc | 1.042M |
| ADMA Biologics Inc | 258.22M |